Cell death and autophagy: Cytokines, drugs, and nutritional factors

被引:115
作者
Burscha, Wilfried [1 ]
Karwan, Anneliese [1 ]
Mayer, Miriam [1 ]
Dornetshuber, Julia [1 ]
Frohwein, Ulrike [1 ]
Schulte-Hermann, Rolf [1 ]
Fazi, Barbara [2 ]
Di Sano, Federica [2 ]
Piredda, Lucia [2 ]
Piacentini, Mauro [2 ]
Petrovski, Goran [3 ]
Fesus, Laszlo [3 ]
Gerner, Christopher [1 ,3 ]
机构
[1] Med Univ Vienna, Dept Med 1, Inst Canc Res, A-1090 Vienna, Austria
[2] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy
[3] Univ Debrecen, Dept Biochem & Mol Biol, Apoptosis & Genom Res Grp, Hungarian Acad Sci,Res Ctr Mol Med, H-4012 Debrecen, Hungary
关键词
Human breast cancer cell line (MCF-7); Human hepatoma cell line (HCC-1.2); Proteomics; Cell injury; Defense; Caspase-3; Phagocytosis; Glucose deprivation; Hexokinase;
D O I
10.1016/j.tox.2008.07.048
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cells may use multiple pathways to commit suicide. In certain contexts, dying cells generate large amounts of autophagic vacuoles and clear large proportions of their cytoplasm, before they finally die, as exemplified by the treatment of human mammary carcinoma cells with the anti-estrogen tamoxifen (TAM, <= 1 mu M). Protein analysis during autophagic cell death revealed distinct proteins of the nuclear fraction including CST-pi and some proteasomal subunit constituents to be affected during autophagic cell death. Depending on the functional status of caspase-3, MCF-7 cells may switch between autophagic and apoptotic features of cell death [Fazi, B., Bursch, W., Fimia, G.M., Nardacci R., Piacentini, M., Di Sano, F., Piredda. L., 2008. Fenretinide induces autophagic cell death in caspase-defective breast cancer cells. Autophagy 4(4), 435-441]. Furthermore, the self-destruction of MCF-7 cells was found to be completed by phagocytosis of cell residues [Petrovski, G., Zahuczky, G., Katona, K., Vereb, G., Martinet. W., Nemes, Z., Bursch, W., Fesus, L., 2007. Clearance of dying autophagic cells of different origin by professional and non-professional phagocytes. Cell Death Diff. 14 (6),1117-1128]. Autophagy also constitutes a cell's strategy of defense upon cell damage by eliminating damaged bulk proteins/organelles. This biological condition may be exemplified by the treatment of MCF-7 cells with a necrogenic TAM-dose (10 mu M), resulting in the lysis of almost all cells within 24 h. However, a transient (1 h) challenge of MCF-7 cells with the same dose allowed the recovery of cells involving autophagy. Enrichment of chaperones in the insoluble cytoplasmic protein fraction indicated the formation of aggresomes, a potential trigger for autophagy. In a further experimental model HL60 cells were treated with TAM, causing dose-dependent distinct responses: 1-5 mu M TAM, autophagy predominant; 7-9 mu M, apoptosis predominant; 15 mu M, necrosis. These phenomena might be attributed to the degree of cell damage caused by tamoxifen, either by generating ROS, increasing membrane fluidity or forming DNA-adducts. Finally, autophagy constitutes a cell's major adaptive (survival) strategy in response to metabolic challenges such as glucose or amino acid deprivation, or starvation in general. Notably, the role of autophagy appears not to be restricted to nutrient recycling in order to maintain energy supply of cells and to adapt cell(organ) size to given physiological needs. For instance, using a newly established hepatoma cell line HCC-1.2, amino acid and glucose deprivation revealed a pro-apoptotic activity, additive to TGF-beta 1.The proapoptotic action of glucose deprivation was antagonized by 2-deoxyglucose, possibly by stabilizing the mitochondrial membrane involving the action of hexokinase II. These observations suggest that signaling cascades steering autophagy appear to provide links to those regulating cell number. Taken together, our data exemplify that a given cell may flexibly respond to type and degree of (micro)environmental changes or cell death stimuli; a cell's response may shift gradually from the elimination of damaged proteins by autophagy and the recovery to autophagic or apoptotic pathways of cell death, the failure of which eventually may result in necrosis. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:147 / 157
页数:11
相关论文
共 87 条
  • [51] Caspase-independent cell death?
    Lockshin, RA
    Zakeri, Z
    [J]. ONCOGENE, 2004, 23 (16) : 2766 - 2773
  • [52] Caspase activation cascades in apoptosis
    Logue, Susan E.
    Martin, Seamus J.
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2008, 36 : 1 - 9
  • [53] Self-eating and self-killing: crosstalk between autophagy and apoptosis
    Maiuri, M. Chiara
    Zalckvar, Einat
    Kimchi, Adi
    Kroemer, Guido
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (09) : 741 - 752
  • [54] Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak
    Majewski, N
    Nogueira, V
    Bhaskar, P
    Coy, PE
    Skeen, JE
    Gottlob, K
    Chandel, NS
    Thompson, CB
    Robey, RB
    Hay, N
    [J]. MOLECULAR CELL, 2004, 16 (05) : 819 - 830
  • [55] Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases
    Majewski, N
    Nogueira, V
    Robey, RB
    Hay, N
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (02) : 730 - 740
  • [56] MAYER M, 2007, BMC PHARM S2, V7, pA64
  • [57] Autophagy fights disease through cellular self-digestion
    Mizushima, Noboru
    Levine, Beth
    Cuervo, Ana Maria
    Klionsky, Danial J.
    [J]. NATURE, 2008, 451 (7182) : 1069 - 1075
  • [58] Autophagy as a second level protective process in conferring resistance to environmentally-induced oxidative stress
    Moore, Michael N.
    [J]. AUTOPHAGY, 2008, 4 (02) : 254 - 256
  • [59] Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy
    Moretti, Luigi
    Yang, Eddy S.
    Kim, Kwang W.
    Lu, Bo
    [J]. DRUG RESISTANCE UPDATES, 2007, 10 (4-5) : 135 - 143
  • [60] Transforming growth factor beta(1)-induced cell death in preneoplastic foci of rat liver and sensitization by the antiestrogen tamoxifen
    Mullauer, L
    GraslKraupp, B
    Bursch, W
    SchulteHermann, R
    [J]. HEPATOLOGY, 1996, 23 (04) : 840 - 847